Literature DB >> 6203420

Palliative gastroenterostomy for pancreatic cancer.

S P Schantz, W Schickler, T K Evans, R J Coffey.   

Abstract

The records of 125 consecutive patients with unresectable pancreatic cancer treated between 1958 and 1979 were evaluated to determine the benefit or morbidity of gastroenterostomy performed on a routine basis. One hundred three patients had no evidence of gastric outlet obstruction from tumor extension as determined at the time of initial operation. Fifty-seven of these patients underwent biliary diversion as their only operative procedure. The morbidity and mortality in this group was 31 and 14 percent, respectively. Six of these 57 patients required decompressing gastroenterostomy at a later date to relieve gastric outlet obstruction. Forty-six patients underwent both biliary and prophylactic gastric outlet diversion with a 15 percent mortality rate and a 46 percent incidence of morbidity. The most common complication in this group was delayed gastric emptying (14 percent). These findings, and the high incidence of delayed gastric emptying after gastroenterostomy and the relatively infrequent occurrence of gastric outlet obstruction (11 percent) after initial biliary diversion, suggest that gastroenterostomy should be performed on a selective basis only.

Entities:  

Mesh:

Year:  1984        PMID: 6203420     DOI: 10.1016/0002-9610(84)90203-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

Review 1.  Neoadjuvant, adjuvant, and palliative treatment of pancreatic cancer.

Authors:  D Birk; H G Beger
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.

Authors:  Kurinchi Selvan Gurusamy; Senthil Kumar; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 3.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

4.  An analysis of when patients eat after gastrojejunostomy.

Authors:  D Fromm; D Resitarits; R Kozol
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

5.  Is modified Devine exclusion necessary for gastrojejunostomy in patients with unresectable pancreatobiliary cancer?

Authors:  Teruyuki Usuba; Takeyuki Misawa; Yoichi Toyama; Yuichi Ishida; Yuji Ishii; Satoru Yanagisawa; Susumu Kobayashi; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

6.  Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas?

Authors:  G P van der Schelling; R P van den Bosch; J H Klinkenbij; P G Mulder; J Jeekel
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

7.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

8.  Risk factors for morbidity and mortality following gastroenterostomy.

Authors:  Martin Poulsen; Mauro Trezza; Ghayyath H Atimash; Lars T Sorensen; Finn Kallehave; Ulla Hemmingsen; Lars N Jorgensen
Journal:  J Gastrointest Surg       Date:  2009-04-28       Impact factor: 3.452

9.  The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Authors:  N Tjarda Van Heek; Steve M M De Castro; Casper H van Eijck; Rutger C I van Geenen; Eric J Hesselink; Paul J Breslau; T C Khe Tran; Geert Kazemier; Mechteld R M Visser; Olivier R C Busch; Hugo Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

10.  'Cross-section gastroenterostomy' in patients with irresectable periampullary carcinoma.

Authors:  O Horstmann; C W Kley; S Post; H Becker
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.